Prostate Cancer Pub Med

Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostate ca...

BioPortfolio - life science, medical devices and pharmaceutical conference

BioPortfolio is an internet agent for Visiongain's life science, medical devices and pharmaceutical conference.

Swine Flu - H1N1 influenza

Swine flu is the common name given to a relatively new strain of influenza (flu) that caused a flu pandemic in 2009-2010. It is also referred to as H1N1 influenza (because it is the H1N1 strain of...

College Hill - international business communications consultancy

College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most...

Oral Contraceptives and Cancer Risk: Questions and Answers

A fact sheet about research on the risk of developing cancer of the breast, cervix, liver, and ovary from the use of oral contraceptives.

Meet the Experts: Discussion About IPOs in the Biotech Industry

Fintan Walton, CEO PharmaVentures, leads this month's international panel in a discussion about IPOs in the biotech industry, drawing on the wide-ranging experiences of our experts to address the prac...

ZymoGenetics: 25 Years Young: An Interview with Bruce Carter, President and CEO

Fintan Walton, CEO of PharmaVentures, talks exclusively to Bruce Carter, President and CEO of ZymoGenetics, a company that celebrated its 25th anniversary on 22 June 2006. Bruce discusses a number of...

Meet the Experts: Discussion About Deal Valuation

This month, Fintan Walton leads our expert panel in a discussion about deal valuation, further exploring the risks and benefits associated with the different methodologies outlined in the business rep...

Meet the Experts: Discussion on Deal Making in Oncology

Fintan Walton leads this month's expert panel discussion on the topic of oncology deal making. The panel explores the issues facing big pharma and small biotech and the alliance strategies they employ...

Meet the Experts: Discussion on Early-Stage Financing of Biotech Companies in Europe

Fintan Walton leads our panel of industry experts in an in-depth discussion about the early-stage financing of biotech companies in Europe. With viewpoints from both financial and biotech companies, o...

Simcere Pharmaceuticals: Dr H Ming Pang, Head of International Business

Dr Pang talks to Fintan Walton about biotechnology trends in China. He examines what the Chinese pharmaceutical and biotechnology industry has to offer the global market, discusses the opportunities i...

Galapagos: Onno van de Stolpe, CEO

Onno van de Stolpe talks to Fintan Walton, about Galapagos' current business model and overall strategic outlook. They discuss the integration of BioFocus following its acquisition by Galapagos in Nov...

Largest health insurers. Based on 2009 healthcare-related revenue from health, life and health statutory fillings.

The new fraud offensive. It's time to stop losing billions to fraud each year and redirect those dollars.

Spelling out the rules. Regulations detail how law will protect consumers.

Road map to better care. U.S. at bottom of Commonwealth Fund's ranking of seven health systems.

Orszag exit looms...as speculation grows over effect on health reform.